| 95F | Name: | 5-ethyl-4-methyl-6-(morpholin-4-yl)pyrimidin-2-amine | Formula: | C11 H18 N4 O | SMILES: | c2(nc(N1CCOCC1)c(c(n2)C)CC)N | InChi: | InChI=1S/C11H18N4O/c1-3-9-8(2)13-11(12)14-10(9)15-4-6-16-7-5-15/h3-7H2,1-2H3,(H2,12,13,14) | Definition date: | 2017-12-22 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | 5-ethyl-4-methyl-6-(morpholin-4-yl)pyrimidin-2-amine |
|
| 95L | Name: | 4-amino-6-fluoroquinoline-3-carbohydrazide | Formula: | C10 H9 F N4 O | SMILES: | NNC(=O)c2cnc1ccc(cc1c2N)F | InChi: | InChI=1S/C10H9FN4O/c11-5-1-2-8-6(3-5)9(12)7(4-14-8)10(16)15-13/h1-4H,13H2,(H2,12,14)(H,15,16) | Definition date: | 2017-12-22 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | 4-amino-6-fluoroquinoline-3-carbohydrazide |
|
| 95R | Name: | (4R)-4-(2-methoxyphenyl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione | Formula: | C16 H17 N O3 | SMILES: | N3C1=C(C(CCC1)=O)C(c2ccccc2OC)CC3=O | InChi: | InChI=1S/C16H17NO3/c1-20-14-8-3-2-5-10(14)11-9-15(19)17-12-6-4-7-13(18)16(11)12/h2-3,5,8,11H,4,6-7,9H2,1H3,(H,17,19)/t11-/m1/s1 | Definition date: | 2017-12-22 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | (4R)-4-(2-methoxyphenyl)-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-dione |
|
| C9L | Name: | 5-ethyl-N4-methyl-6-piperidin-1-yl-pyrimidine-2,4-diamine | Formula: | C12 H21 N5 | SMILES: | CCc1c(NC)nc(N)nc1N2CCCCC2 | InChi: | InChI=1S/C12H21N5/c1-3-9-10(14-2)15-12(13)16-11(9)17-7-5-4-6-8-17/h3-8H2,1-2H3,(H3,13,14,15,16) | Definition date: | 2019-04-18 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | 5-ethyl-~{N}4-methyl-6-piperidin-1-yl-pyrimidine-2,4-diamine |
|
| CEU | Name: | N4-methyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine | Formula: | C10 H18 N6 | SMILES: | CNc1cc(nc(N)n1)N2CCN(C)CC2 | InChi: | InChI=1S/C10H18N6/c1-12-8-7-9(14-10(11)13-8)16-5-3-15(2)4-6-16/h7H,3-6H2,1-2H3,(H3,11,12,13,14) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-methyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine |
|
| CG0 | Name: | N4-cyclopropyl-5-ethyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine | Formula: | C14 H24 N6 | SMILES: | CCc1c(NC2CC2)nc(N)nc1N3CCN(C)CC3 | InChi: | InChI=1S/C14H24N6/c1-3-11-12(16-10-4-5-10)17-14(15)18-13(11)20-8-6-19(2)7-9-20/h10H,3-9H2,1-2H3,(H3,15,16,17,18) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-5-ethyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine |
|
| CGX | Name: | N4-cyclopropyl-5-ethyl-6-piperidin-1-yl-pyrimidine-2,4-diamine | Formula: | C14 H23 N5 | SMILES: | CCc1c(NC2CC2)nc(N)nc1N3CCCCC3 | InChi: | InChI=1S/C14H23N5/c1-2-11-12(16-10-6-7-10)17-14(15)18-13(11)19-8-4-3-5-9-19/h10H,2-9H2,1H3,(H3,15,16,17,18) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-5-ethyl-6-piperidin-1-yl-pyrimidine-2,4-diamine |
|
| CJ0 | Name: | N4-methyl-6-morpholin-4-yl-pyrimidine-2,4-diamine | Formula: | C9 H15 N5 O | SMILES: | CNc1cc(nc(N)n1)N2CCOCC2 | InChi: | InChI=1S/C9H15N5O/c1-11-7-6-8(13-9(10)12-7)14-2-4-15-5-3-14/h6H,2-5H2,1H3,(H3,10,11,12,13) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-methyl-6-morpholin-4-yl-pyrimidine-2,4-diamine |
|
| CJ6 | Name: | N4-cyclopropyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine | Formula: | C12 H20 N6 | SMILES: | CN1CCN(CC1)c2cc(NC3CC3)nc(N)n2 | InChi: | InChI=1S/C12H20N6/c1-17-4-6-18(7-5-17)11-8-10(14-9-2-3-9)15-12(13)16-11/h8-9H,2-7H2,1H3,(H3,13,14,15,16) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-6-(4-methylpiperazin-1-yl)pyrimidine-2,4-diamine |
|
| CJ9 | Name: | N4-cyclopropyl-6-piperidin-1-yl-pyrimidine-2,4-diamine | Formula: | C12 H19 N5 | SMILES: | Nc1nc(NC2CC2)cc(n1)N3CCCCC3 | InChi: | InChI=1S/C12H19N5/c13-12-15-10(14-9-4-5-9)8-11(16-12)17-6-2-1-3-7-17/h8-9H,1-7H2,(H3,13,14,15,16) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-6-piperidin-1-yl-pyrimidine-2,4-diamine |
|
| CJF | Name: | N4-cyclopropyl-6-morpholin-4-yl-pyrimidine-2,4-diamine | Formula: | C11 H17 N5 O | SMILES: | Nc1nc(NC2CC2)cc(n1)N3CCOCC3 | InChi: | InChI=1S/C11H17N5O/c12-11-14-9(13-8-1-2-8)7-10(15-11)16-3-5-17-6-4-16/h7-8H,1-6H2,(H3,12,13,14,15) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-6-morpholin-4-yl-pyrimidine-2,4-diamine |
|
| CJL | Name: | N4-cyclopropyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyrimidine-2,4-diamine | Formula: | C14 H22 N6 O | SMILES: | Nc1nc(NC2CC2)cc(n1)N3CCN(CC3)C4COC4 | InChi: | InChI=1S/C14H22N6O/c15-14-17-12(16-10-1-2-10)7-13(18-14)20-5-3-19(4-6-20)11-8-21-9-11/h7,10-11H,1-6,8-9H2,(H3,15,16,17,18) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-cyclopropyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyrimidine-2,4-diamine |
|
| CJR | Name: | N4-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyrimidine-2,4-diamine | Formula: | C12 H20 N6 O | SMILES: | CNc1cc(nc(N)n1)N2CCN(CC2)C3COC3 | InChi: | InChI=1S/C12H20N6O/c1-14-10-6-11(16-12(13)15-10)18-4-2-17(3-5-18)9-7-19-8-9/h6,9H,2-5,7-8H2,1H3,(H3,13,14,15,16) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-methyl-6-[4-(oxetan-3-yl)piperazin-1-yl]pyrimidine-2,4-diamine |
|
| CJU | Name: | N4-methyl-6-piperidin-1-yl-pyrimidine-2,4-diamine | Formula: | C10 H17 N5 | SMILES: | CNc1cc(nc(N)n1)N2CCCCC2 | InChi: | InChI=1S/C10H17N5/c1-12-8-7-9(14-10(11)13-8)15-5-3-2-4-6-15/h7H,2-6H2,1H3,(H3,11,12,13,14) | Definition date: | 2019-04-24 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | ~{N}4-methyl-6-piperidin-1-yl-pyrimidine-2,4-diamine |
|
| E4X | Name: | 4-bromo-N-((1S,2R)-2-(naphthalen-1-yl)-1-(5-oxo-4,5-dihydro-1,3,4-oxadiazol-2-yl)propyl)benzenesulfonamide | Formula: | C21 H18 Br N3 O4 S | SMILES: | C[CH]([CH](N[S](=O)(=O)c1ccc(Br)cc1)C2=NNC(=O)O2)c3cccc4ccccc34 | InChi: | InChI=1S/C21H18BrN3O4S/c1-13(17-8-4-6-14-5-2-3-7-18(14)17)19(20-23-24-21(26)29-20)25-30(27,28)16-11-9-15(22)10-12-16/h2-13,19,25H,1H3,(H,24,26)/t13-,19+/m1/s1 | Definition date: | 2019-10-16 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | 4-bromanyl-~{N}-[(1~{S},2~{R})-2-naphthalen-1-yl-1-(2-oxidanylidene-3~{H}-1,3,4-oxadiazol-5-yl)propyl]benzenesulfonamide |
|
| EDX | Name: | (2~{S})-6-carbamimidamido-2-(phenylmethoxycarbonylamino)hexanoic acid | Formula: | C15 H22 N4 O4 | SMILES: | NC(=N)NCCCC[CH](NC(=O)OCc1ccccc1)C(O)=O | InChi: | InChI=1S/C15H22N4O4/c16-14(17)18-9-5-4-8-12(13(20)21)19-15(22)23-10-11-6-2-1-3-7-11/h1-3,6-7,12H,4-5,8-10H2,(H,19,22)(H,20,21)(H4,16,17,18)/t12-/m0/s1 | Definition date: | 2019-12-13 | Last modified: | 2020-10-23 | Release date: | 2020-10-28 | Identifier: | (2~{S})-6-carbamimidamido-2-(phenylmethoxycarbonylamino)hexanoic acid |
|
| QEL | Name: | 4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol | Formula: | C21 H27 N O2 | SMILES: | OC(c1ccc(O)cc1)C(N2CCC(CC2)Cc3ccccc3)C | InChi: | InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3/t16-,21-/m0/s1 | Synonyms: | Ifenprodil | Definition date: | 2011-01-28 | Last modified: | 2020-10-21 | Identifier: | 4-[(1R,2S)-2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol |
|
| UOV | Name: | N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide | Formula: | C21 H24 N2 O2 | SMILES: | C1N(CCC2(C1)CCO2)C(=O)Nc4ccc(c3ccc(C)cc3)cc4 | InChi: | InChI=1S/C21H24N2O2/c1-16-2-4-17(5-3-16)18-6-8-19(9-7-18)22-20(24)23-13-10-21(11-14-23)12-15-25-21/h2-9H,10-15H2,1H3,(H,22,24) | Definition date: | 2020-05-26 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | N-(4'-methyl[1,1'-biphenyl]-4-yl)-1-oxa-7-azaspiro[3.5]nonane-7-carboxamide |
|
| N07 | Name: | [3'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-3-yl](piperidin-1-yl)methanone | Formula: | C21 H21 N3 O2 | SMILES: | Cc1nnc(o1)c2cccc(c2)c3cccc(c3)C(=O)N4CCCCC4 | InChi: | InChI=1S/C21H21N3O2/c1-15-22-23-20(26-15)18-9-5-7-16(13-18)17-8-6-10-19(14-17)21(25)24-11-3-2-4-12-24/h5-10,13-14H,2-4,11-12H2,1H3 | Definition date: | 2019-04-26 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | [3'-(5-methyl-1,3,4-oxadiazol-2-yl)[1,1'-biphenyl]-3-yl](piperidin-1-yl)methanone |
|
| QR8 | Name: | (3~{R},4~{S},5~{R},6~{S},7~{S},9~{S},11~{R},12~{S},13~{R},14~{R})-3,5,7,9,11,13,14-heptamethyl-4,6,12-tris(oxidanyl)-1-oxacyclotetradecane-2,10-dione | Formula: | C20 H36 O6 | SMILES: | C[CH]1C[CH](C)C(=O)[CH](C)[CH](O)[CH](C)[CH](C)OC(=O)[CH](C)[CH](O)[CH](C)[CH]1O | InChi: | InChI=1S/C20H36O6/c1-9-8-10(2)17(22)13(5)19(24)14(6)20(25)26-15(7)11(3)18(23)12(4)16(9)21/h9-15,17-19,22-24H,8H2,1-7H3/t9-,10-,11-,12-,13+,14+,15+,17-,18-,19-/m0/s1 | Definition date: | 2020-07-28 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | (3~{R},4~{S},5~{R},6~{S},7~{S},9~{S},11~{R},12~{S},13~{R},14~{R})-3,5,7,9,11,13,14-heptamethyl-4,6,12-tris(oxidanyl)-1-oxacyclotetradecane-2,10-dione |
|
| YO3 | Name: | YO3-biotin | Formula: | C21 H19 N2 O | SMILES: | CN2C=CC(c1c2cccc1)=[C@H][C@H]=[C@H]c3[n+](c4c(o3)cccc4)C | InChi: | InChI=1S/C21H19N2O/c1-22-15-14-16(17-9-3-4-10-18(17)22)8-7-13-21-23(2)19-11-5-6-12-20(19)24-21/h3-15H,1-2H3/q+1 | Synonyms: | 3-methyl-2-[(1E,3E)-3-(1-methylquinolin-4(1H)-ylidene)prop-1-en-1-yl]-1,3-benzoxazol-3-ium | Definition date: | 2019-10-17 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 3-methyl-2-[(1E,3E)-3-(1-methylquinolin-4(1H)-ylidene)prop-1-en-1-yl]-1,3-benzoxazol-3-ium |
|
| VU7 | Name: | 6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-N-methoxy-3-methylquinoline-4-carboxamide | Formula: | C24 H18 F2 N2 O2 | SMILES: | CONC(=O)c1c(C)c(nc2c1cc(cc2)F)c4ccc(c3c(cccc3)F)cc4 | InChi: | InChI=1S/C24H18F2N2O2/c1-14-22(24(29)28-30-2)19-13-17(25)11-12-21(19)27-23(14)16-9-7-15(8-10-16)18-5-3-4-6-20(18)26/h3-13H,1-2H3,(H,28,29) | Definition date: | 2020-09-15 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-N-methoxy-3-methylquinoline-4-carboxamide |
|
| V0Y | Name: | 4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl]-2-fluorobenzonitrile | Formula: | C24 H23 F2 N5 O2 | SMILES: | N#Cc1c(cc(cc1)C=3N=C(N2CCC(N)CC2)N(C(C=3c4cc(F)c(OC)cc4)=O)C)F | InChi: | InChI=1S/C24H23F2N5O2/c1-30-23(32)21(14-5-6-20(33-2)19(26)11-14)22(15-3-4-16(13-27)18(25)12-15)29-24(30)31-9-7-17(28)8-10-31/h3-6,11-12,17H,7-10,28H2,1-2H3 | Definition date: | 2020-06-11 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 4-[2-(4-aminopiperidin-1-yl)-5-(3-fluoro-4-methoxyphenyl)-1-methyl-6-oxo-1,6-dihydropyrimidin-4-yl]-2-fluorobenzonitrile |
|
| R1Q | Name: | vincristine | Formula: | C46 H56 N4 O10 | SMILES: | CC[C]1(O)C[CH]2C[N](CCc3c([nH]c4ccccc34)[C](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[CH]7[C](O)([CH](OC(C)=O)[C]8(CC)C=CCN9CC[C]67[CH]89)C(=O)OC)C1 | InChi: | InChI=1S/C46H56N4O10/c1-7-42(55)22-28-23-45(40(53)58-5,36-30(14-18-48(24-28)25-42)29-12-9-10-13-33(29)47-36)32-20-31-34(21-35(32)57-4)50(26-51)38-44(31)16-19-49-17-11-15-43(8-2,37(44)49)39(60-27(3)52)46(38,56)41(54)59-6/h9-13,15,20-21,26,28,37-39,47,55-56H,7-8,14,16-19,22-25H2,1-6H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1 | Definition date: | 2020-08-25 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 |
|
| ND5 | Name: | 3-[(~{E})-[3,5-bis(bromanyl)-2-oxidanyl-phenyl]methylideneamino]oxypropanoic acid | Formula: | C10 H9 Br2 N O4 | SMILES: | OC(=O)CCON=Cc1cc(Br)cc(Br)c1O | InChi: | InChI=1S/C10H9Br2NO4/c11-7-3-6(10(16)8(12)4-7)5-13-17-2-1-9(14)15/h3-5,16H,1-2H2,(H,14,15)/b13-5+ | Definition date: | 2019-11-22 | Last modified: | 2020-10-16 | Release date: | 2020-10-21 | Identifier: | 3-[(~{E})-[3,5-bis(bromanyl)-2-oxidanyl-phenyl]methylideneamino]oxypropanoic acid |
|